Revolutionizing Your Pet's Health
Introducing BRAVECTO® TriUNO
This innovative product from Merck Animal Health provides an all-in-one solution for protecting dogs from fleas, ticks, mites, and intestinal parasites.
About BRAVECTO® TriUNO
BRAVECTO TriUNO, recently approved by the European Commission, offers a revolutionary approach to pet health. This chewable tablet provides broad-spectrum protection, targeting fleas, ticks, roundworms, hookworms, heartworms, and lungworms—all in a single dose. Designed for dogs and puppies as young as 8 weeks old and weighing at least 1.27 kg, it delivers unparalleled convenience and peace of mind for pet owners and veterinarians alike.
What the Experts are Saying
“Merck Animal Health is committed to enabling more convenient options for comprehensive parasitic protection for pets and their owners,” said Jason Drake, DVM, DACVM-Parasitology director, scientific marketing affairs, Global Companion Animal Parasiticides, Merck Animal Health. “This new addition to our BRAVECTO portfolio provides easy-to-administer protection for pets against a broader range of parasites. While most pet owners understand the importance of protection against fleas and ticks, it’s equally important to protect pets from internal parasites as both can lead to further health issues and disease. With a single medication, pet owners can feel assured their pets are protected from all sides.”
Revolutionary Pet Protection
Advanced Defense
A new formulation of BRAVECTO for dogs that targets both internal and external parasites.
Long-Lasting Effectiveness
Treats existing fleas and ticks on dogs fast following treatment and continues to kill newly acquired fleas and ticks for an entire month following treatment
Vet-Approved Formula
BRAVECTO has provided long-lasting flea and tick protection, with more than 350 million doses distributed in 100 countries.
Easy Administration
It’s available as a flavored chewable tablet indicated for dogs and puppies from 8 weeks of age